Catalog

This course meets the Kentucky APRN Requirements

Contact Hour(s): 

 2.5 Contact hours, including 2.5 Advanced Pharmacology Hours

Author:

Raymond Lengel, MSN, FNP-BC, RN

This peer-reviewed course is applicable for the following professions:

Advanced Practice Registered Nurse (APRN), Athletic Trainer (AT/AL), Certified Nurse Midwife, Certified Nurse Practitioner, Certified Registered Nurse Anesthetist (CRNA), Certified Registered Nurse Practitioner, Clinical Nurse Specialist (CNS), Licensed Practical Nurse (LPN), Licensed Vocational Nurses (LVN), Midwife (MW), Nursing Student, Occupational Therapist (OT), Occupational Therapist Assistant (OTA), Physical Therapist (PT), Physical Therapist Assistant (PTA), Registered Nurse (RN), Registered Nurse Practitioner

Accreditations: 

The American Nurses Credentialing Center (ANCC), The American Occupational Therapy Association (AOTA), Board of Certification for Athletic Trainers (BOC)

State Approvals:

• Alabama, Provider #ABNP1485; California BRN Provider #CEP # 13509; Florida Physical Therapy Association Approval: CE26-1313828; Kentucky Board of Nursing Provider #7-0085; Florida Board of Nursing Provider 50-353; New York State Education Department’s State Board for Physical Therapy

Course Description:

This course discusses addiction by defining key terms, differentiating between various substance use disorders, and outlining diagnostic criteria. It also covers the risks associated with opioid medications, patient evaluation techniques, and compares treatment options such as methadone, buprenorphine, and naltrexone. Upon completion, participants will be better equipped to assess and manage addiction disorders in clinical settings. This course meets the Kentucky APRN Requirements. 

Outcomes:

≥ 92% of participants will know how to assess and manage addiction.

Objectives:

After completing this continuing education course, the participant will be able to:

1. Define addiction and other terms associated with substance abuse.
2. Compare and contrast substance use disorder (SUD), opioid use disorder (OUD), alcohol use disorder (AUD), and cannabis use disorder (CUD).
3. Describe the risks of abuse and addiction to opioid medications.
4. Summarize the evaluation of a patient with a SUD.
5. Compare and contrast the use of methadone, buprenorphine, and naltrexone in the management of OUD.
6. Identify five professional standards of 201 KAR 20:065 for prescribing Buprenorphine-monoproduct or Buprenorphine/Naloxone.

 Disclosures:

CEUFast Inc. and the course planning team for this educational activity do not have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Contact Hour(s): 2.5 Contact hours, including 2.5 Advanced Pharmacology Hours

Author: Breann Kakacek, BSN, RN

This peer-reviewed course is applicable for the following professions:
Advanced Practice Registered Nurse (APRN), CCI Credentialed Specialists, Certified Nurse Midwife, Certified Nurse Practitioner, Certified Registered Nurse Practitioner, Clinical Nurse Specialist (CNS), Licensed Practical Nurse (LPN), Licensed Vocational Nurses (LVN), Midwife (MW), Nursing Student, Registered Nurse (RN), Registered Nurse Practitioner

Accreditations: 
The American Nurses Credentialing Center (ANCC)

State Approvals:

Alabama, Provider #ABNP1485; California BRN Provider #CEP # 13509; Kentucky Board of Nursing Provider #7-0085; Florida Board of Nursing Provider 50-353.

Course Description:
This course comprehensively examines blood clot management strategies. Learners will explore the mechanisms of action of various medications, including anticoagulants, antiplatelets, and fibrinolytics. The course will differentiate between appropriate uses and contraindications for each medication by examining specific clinical scenarios. In addition, the course will address the identification of bleeding risk factors and mitigation strategies, along with the interpretation of common coagulation tests used to monitor therapy effectiveness. This course is designed for healthcare professionals and individuals seeking a deeper understanding of blood clot management.

Outcomes:

≥ 92% of participants will know the appropriate use and limitations of various anticoagulant, antiplatelet, and fibrinolytic medications based on mechanisms of action and clinical scenarios.

Objectives:
After completing this continuing education course, the participant will be able to:

1. Analyze the risk factors for bleeding complications in patients receiving anticoagulant or fibrinolytic therapy.
2. Evaluate the potential benefits and risks of anticoagulant and fibrinolytic therapy for patients with specific conditions.
3. Develop a comprehensive patient education plan on using anticoagulant or fibrinolytic therapy medications safely and effectively.
4. Identify four different classes of anticoagulant medications and their mechanisms of action.
5. Differentiate between the indications and contraindications for various anticoagulant and fibrinolytic therapies.
6. Implement strategies to minimize bleeding risks in patients receiving anticoagulant therapy.
7. Compare and contrast the mechanisms of action of aspirin, heparin, direct oral anticoagulants (DOACs), and warfarin.
8. Interpret laboratory results of common coagulation tests to monitor the effectiveness and safety of anticoagulants and fibrinolytic therapy.

Disclosures:
CEUFast Inc. and the course planning team for this educational activity do not have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Contact Hour(s): 

1 Contact Hour including 1 Advanced Pharmacology Hour 

Author:

Nick Angelis, CRNA, MSN

This peer-reviewed course is applicable for the following professions:

Advanced Practice Registered Nurse (APRN), Certified Nurse Midwife, Certified Nurse Practitioner, Certified Registered Nurse Anesthetist (CRNA), Certified Registered Nurse Practitioner, Clinical Nurse Specialist (CNS), Licensed Practical Nurse (LPN), Licensed Vocational Nurses (LVN), Midwife (MW), Nursing Student, Registered Nurse (RN), Respiratory Care Practitioner, Respiratory Therapist (RT) 

Accreditations: 

The American Nurses Credentialing Center (ANCC)

State Approvals:

Course Description:

This course discusses lung physiology and mechanics, common drugs for sedation and analgesia, ways to assess sedation and pain, and the healthcare professional’s role in sedation.

Outcomes:

≥ 92% of participants will know how to improve their care by synthesizing new knowledge about common sedation drugs and pain scales to better monitor and predict patient responses.

Objectives:

After completing this continuing education course, the participant will be able to:

1. Summarize the pathophysiology of breathing and the role of breathing in a sedated patient.
2. Describe practical approaches and treatment for sedated patients.
3. Explain the components of assessing sedation levels and pain.
4. Outline the importance of patient safety and comfort with attentive care.
5. Determine the healthcare professional's role for sedated patients.

Disclosures:

CEUFast Inc. and the course planning team for this educational activity do not have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Contact Hour(s): 

1 Contact Hour including 1 Pharmacology Hour

Author:

Dana Bartlett, RN, BSN, MA, MA, CSPI

This peer-reviewed course is applicable for the following professions:

Advanced Practice Registered Nurse (APRN), Certified Nurse Midwife, Certified Nurse Practitioner, Certified Registered Nurse Anesthetist (CRNA), Certified Registered Nurse Practitioner, Clinical Nurse Specialist (CNS), Dietetic Technicians, Registered (DTR), Dietitian/Nutritionist (RDN), Licensed Practical Nurse (LPN), Licensed Vocational Nurses (LVN), Midwife (MW), Nursing Student, Occupational Therapist (OT), Occupational Therapist Assistant (OTA), Physical Therapist (PT), Physical Therapist Assistant (PTA), Registered Nurse (RN)

Accreditations:

The American Nurses Credentialing Center (ANCC)

State Approvals:

Alabama, Provider #ABNP1485; California BRN Provider #CEP # 13509; Florida Physical Therapy Association Approval: CE26-650617; Kentucky Board of Nursing Provider #7-0085; Florida Board of Nursing Provider 50-353; Nevada Board of Physical Therapy; New York State Education Department’s State Board for Physical Therapy

Course Description: 

This course discusses the microvascular complications of diabetes. Specific microvascular complications, including diabetic nephropathy, diabetic neuropathy, and diabetic retinopathy, are outlined. The epidemiology, pathophysiology, risk factors, signs/symptoms, treatment, and prevention of these complications are discussed.

Outcomes 

≥ 92% of participants will know the microvascular complications of diabetes, and the signs/symptoms, risk factors, and treatments for these complications.

Objectives 

After completing this module, the learner will be able to:

1. Summarize the microvascular complications of diabetes.
2. Identify risk factors associated with developing diabetic microvascular complications.
3. Evaluate screening and diagnosis methods of diabetic microvascular complications.
4. Outline interventions used to treat diabetic microvascular complications.
5. Paraphrase prevention methods of diabetic microvascular complications.

Disclosures: 

Contact Hour(s): 

1 Contact Hour, including 1 Advanced Pharmacology Hour

Author:

James Wittenauer, RN, MSN, MPA, RN-BC

This peer-reviewed course is applicable for the following professions: 

Advanced Practice Registered Nurse (APRN), Certified Nurse Midwife, Certified Nurse Practitioner, Certified Registered Nurse Anesthetist (CRNA), Clinical Nurse Specialist (CNS), Licensed Practical Nurse (LPN), Licensed Vocational Nurses (LVN), Nursing Student, Registered Nurse (RN), Registered Nurse Practitioner

Accreditations: 

The American Nurses Credentialing Center (ANCC)

Course Description:

This course discusses the use of diuretics in detail. It will cover all classes of diuretics to include their respective methods of action, intended effects, and side effects. In addition, this course will describe the nursing considerations and patient teaching that is necessary for patients prescribed diuretic medications.

Outcomes:

≥ 92% of participants will know how to safely administer diuretics.

Objectives:

After completing this continuing education course, the participant will be able to:

1. Explain why diuretics are prescribed.
2. List the main classes of diuretics.
3. Delineate the mechanism of action for each class of diuretics.
4. Differentiate the contraindications for giving a diuretic.
5. Describe the nursing considerations when giving diuretics.

Disclosures:

CEUFast Inc. and the course planning team for this educational activity do not have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Contact Hour(s): 

2 Contact Hours, including 2 Pharmacology Hours

Author:

Heather Rhodes, APRN-BC

This peer-reviewed course is applicable for the following professions:

Advanced Practice Registered Nurse (APRN), Certified Nurse Practitioner, Certified Registered Nurse Practitioner, Clinical Nurse Specialist (CNS), Licensed Practical Nurse (LPN), Licensed Vocational Nurses (LVN), Nursing Student, Registered Nurse (RN), Registered Nurse Practitioner

Accreditations: 

The American Nurses Credentialing Center (ANCC)

State Approvals:

Alabama, Provider #ABNP1485; California BRN Provider #CEP # 13509; Kentucky Board of Nursing Provider #7-0085; Florida Board of Nursing Provider 50-353

Course Description:

This course discusses what pharmacogenomic testing is and how it can benefit patients. Genes, pathways, and drug-drug interactions are also outlined.

Outcomes:

≥ 92% of participants will understand pharmacogenomic testing indications, the benefits of testing, how to perform the test, read the results, and be able to recommend treatment options.

Objectives:

After completing this continuing education course, the participant will be able to:

1. Describe what pharmacogenomic testing is and how it helps patients.
2. Describe who regulates pharmacogenomic testing.
3. Determine patients who are appropriate for pharmacogenomic testing.
4. Explain the difference between pharmacodynamic and pharmacokinetic genes.
5. Compare cytochrome P450 (CYP) enzymatic pathways.
6. Recall the most common mechanism leading to drug-drug interactions.

Disclosures:

CEUFast Inc. and the course planning team for this educational activity do not have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Contact Hour(s): 

2 Contact Hours, including 2 Advanced Pharmacology Hours and 1 Category A Hour

Author:

Desiree Reinken, PhD, APRN, NP-C

This peer-reviewed course is applicable for the following professions:

Advanced Practice Registered Nurse (APRN), Certified Nurse Midwife, Certified Nurse Practitioner, Certified Registered Nurse Anesthetist (CRNA), Certified Registered Nurse Practitioner, Clinical Nurse Specialist (CNS)

Accreditations: 

The American Nurses Credentialing Center (ANCC)

State Approvals: 

The continuing education activity was approved by the Ohio Nurses Association, an Ohio Board of Nursing approver. (OBN-001-91) ONA #2023-0000000648.

Alabama, Provider #ABNP1485; California BRN Provider #CEP # 13509; Kentucky Board of Nursing Provider #7-0085; Florida Board of Nursing Provider 50-353;

Course Description:

This course discusses state and federal laws associated with APRN prescriptive authority in the state of Ohio. It also discusses the governor's cabinet opiate action team (GCOAT) recommendations and the governor's recoveryOhio initiative. This course also includes information on pharmacologic options, such as opioids and benzodiazepines, and their contraindications. Non-pharmacologic treatment options are also highlighted.

Outcomes:

≥ 92% of participants will know how to prescribe controlled substances based on best practices and Ohio law.

Objectives:

After completing this continuing education course, the participant will be able to:

1. Identify state and federal laws related to prescribing drugs.
2. Explain alternatives to opioid therapy.
3. Outline indications and contraindications for opioids.
4. Describe indications and contraindications for benzodiazepines.
5. Summarize the governor's cabinet opiate action team (GCOAT) recommendations and the governor's Recovery Ohio initiative.

Disclosures:

CEUFast Inc. and the course planning team for this educational activity do not have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Contact Hour(s): 

2 Contact Hours, including 2 Advanced Pharmacology Hours

Author:

Julia Tortorice, RN, MBA, MSN, NEA-BC, CPHQ

This peer-reviewed course is applicable for the following professions:

Licensed Practical Nurse (LPN), Licensed Vocational Nurses (LVN), Nursing Student, Registered Nurse (RN), Respiratory Care Practitioner, Respiratory Therapist (RT)

Accreditations: 

The American Nurses Credentialing Center (ANCC)

Course Description:

Oxygen (O2) commonly treats medical conditions with poor tissue and arterial oxygenation. This course examines the clinical recommendations for using O2 therapy in different disease conditions.

Outcomes:

≥92% of participants will know best practices for oxygen delivery.

Objectives:

After completing this continuing education course, the participant will be able to:

1. Explain the various options in oxygen therapy delivery.
2. Compare and contrast the practice recommendations for oxygen therapy indications in special diagnoses and presentations.
3. Analyze practice recommendations for oxygen therapy initiation.
4. Outline the monitoring, dispensing, and documentation requirements for oxygen therapy.
5. Describe oxygen therapy discontinuation practices.

Disclosures:

CEUFast Inc. and the course planning team for this educational activity do not have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Contact Hour(s): 

2 Contact Hours, including 2 Pharmacology Hours

Author:

Sarah Beattie, DNP, APRN-CNP, CDCES

This peer-reviewed course is applicable for the following professions:

Advanced Practice Registered Nurse (APRN), Athletic Trainer (AT/AL), Certified Nurse Midwife, Certified Nurse Practitioner, Certified Registered Nurse Practitioner, Clinical Nurse Specialist (CNS), Dietetic Technicians, Registered (DTR), Dietitian/Nutritionist (RDN), Licensed Practical Nurse (LPN), Licensed Vocational Nurses (LVN), Midwife (MW), Nursing Student, Occupational Therapist (OT), Occupational Therapist Assistant (OTA), Physical Therapist (PT), Physical Therapist Assistant (PTA), Registered Nurse (RN), Registered Nurse Practitioner, Respiratory Care Practitioner, Respiratory Therapist (RT)

Accreditations: 

The American Nurses Credentialing Center (ANCC), The American Occupational Therapy Association (AOTA), Board of Certification for Athletic Trainers (BOC)

State Approvals:

Alabama, Provider #ABNP1485; California BRN Provider #CEP # 13509; Florida Physical Therapy Association Approval: CE26-1239158; Kentucky Board of Nursing Provider #7-0085; Florida Board of Nursing Provider 50-353; Nevada Board of Physical Therapy; New York State Education Department’s State Board for Physical Therapy

Course Description:

This course discusses the multifactorial etiology, risk factors, comorbid conditions, treatment, and nursing care of pediatric patients diagnosed with obesity.

Outcomes:

≥ 92% of participants will know how to care for pediatric patients diagnosed with obesity.

Objectives:

After completing this continuing education course, the participant will be able to:

1. Define the diagnostic criteria for pediatric obesity.
2. Identify risk factors for pediatric obesity.
3. Specify three comorbid conditions related to obesity.
4. Describe the socioeconomic impact on pediatric obesity.
5. Summarize the healthcare professional's role in combating pediatric obesity.
6. Explain the treatment options available for treating pediatric obesity.

Disclosures:

CEUFast Inc. and the course planning team for this educational activity do not have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Contact Hour(s): 

3 Contact Hours, including 3 Advanced Pharmacology Hours

Author:

Raymond Lengel, MSN, FNP-BC, RN

This peer-reviewed course is applicable for the following professions:

Advanced Practice Registered Nurse (APRN), CCI Credentialed Specialists, Certified Nurse Midwife, Certified Nurse Practitioner, Certified Registered Nurse Practitioner, Clinical Nurse Specialist (CNS), Licensed Practical Nurse (LPN), Licensed Vocational Nurses (LVN), Midwife (MW), Nursing Student, Occupational Therapist (OT), Occupational Therapist Assistant (OTA), Physical Therapist (PT), Physical Therapist Assistant (PTA), Registered Nurse (RN)

Accreditations: 

The American Nurses Credentialing Center (ANCC), The American Occupational Therapy Association (AOTA)

State Approvals:

Alabama, Provider #ABNP1485; California BRN Provider #CEP # 13509; Florida Physical Therapy Association Approval: CE26-1251582; Kentucky Board of Nursing Provider #7-0085; Florida Board of Nursing Provider 50-353; New York State Education Department’s State Board for Physical Therapy

Course Description:

The course will provide an overview of pharmacology, raise awareness and understanding of the various aspects of pharmacology, and increase the nurse's knowledge base.

Outcomes:

≥ 92% of participants will improve their knowledge of pharmacology and knowledge related to medication management.

Objectives:

After completing this continuing education course, the participant will be able to:

1. Relate the ten rules that serve as the standard for legal accountability in drug administration.
2. Outline common principles of pharmacokinetics.
3. Identify the types of patients who require special consideration when administering drugs.
4. Summarize the role of drugs and therapeutic devices in preventing disease and maintaining health.
5. Specify the indications and adverse effects of major categories of drugs.
6. List common agents included in each category of drugs.
7. Identify nursing considerations for each category of drug.
8. Describe common drug errors that are avoidable and strategies to avoid them.

Disclosures:

CEUFast Inc. and the course planning team for this educational activity do not have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Contact Hour(s): 

2 Contact Hours including 2 Advanced Pharmacology Hours

Author:

Mariya Rizwan, PharmD

This peer-reviewed course is applicable for the following professions:

Advanced Practice Registered Nurse (APRN), Certified Nurse Midwife, Certified Nurse Practitioner, Certified Registered Nurse Anesthetist (CRNA), Certified Registered Nurse Practitioner, Clinical Nurse Specialist (CNS), Licensed Practical Nurse (LPN), Licensed Vocational Nurses (LVN), Midwife (MW), Nursing Student, Registered Nurse (RN), Registered Nurse Practitioner

Accreditations: 

The American Nurses Credentialing Center (ANCC)

State Approvals:

Alabama, Provider #ABNP1485; California BRN Provider #CEP # 13509; Kentucky Board of Nursing Provider #7-0085; Florida Board of Nursing Provider 50-353

Course Description:

This course discusses protein synthesis inhibitors and their pharmacology in detail to educate healthcare professionals.

Outcomes:

≥ 92% of participants will know comprehensive knowledge about protein synthesis inhibitors, including their mechanisms of action, classifications, indications, antimicrobial spectrum, pharmacokinetics, potential side effects, toxicity, drug interactions, contraindications, and patient-specific considerations.

Objectives:

After completing this continuing education course, the participant will be able to:

1. Describe the mechanism of action and classify each group of protein synthesis inhibitors.
2. Summarize indications and antimicrobial spectrum for each group of protein synthesis inhibitors.
3. Identify the side effects, toxicity, and dosage for each group of protein synthesis inhibitors.
4. Outline the specific patient parameters that should be assessed before administering each group of protein synthesis inhibitors.
5. Explain the drug interactions, warnings, healthcare considerations, and contraindications for each protein synthesis inhibitor.

Disclosures:

CEUFast Inc. and the course planning team for this educational activity do not have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Contact Hour(s): 

2 Contact Hours, including 2 Advanced Pharmacology Hours

Author:

James Wittenauer, RN, MSN, MPA, RN-BC

This peer-reviewed course is applicable for the following professions:

Advanced Practice Registered Nurse (APRN), CCI Credentialed Specialists, Certified Nurse Midwife, Certified Nurse Practitioner, Certified Registered Nurse Anesthetist (CRNA), Certified Registered Nurse Practitioner, Clinical Nurse Specialist (CNS), Licensed Practical Nurse (LPN), Licensed Vocational Nurses (LVN), Midwife (MW), Nursing Student, Occupational Therapist (OT), Occupational Therapist Assistant (OTA), Physical Therapist (PT), Physical Therapist Assistant (PTA), Registered Nurse (RN), Registered Nurse Practitioner

Accreditations: 

The American Nurses Credentialing Center (ANCC)

State Approvals:

Alabama, Provider #ABNP1485; California BRN Provider #CEP # 13509; Kentucky Board of Nursing Provider #7-0085; Florida Board of Nursing Provider 50-353

Course Description:

This course discusses reasons for using vasoactive medications in an intensive care environment. The course examines the various uses of vasoactive medications and the contraindications and safety measures needed to administer them safely. The course also discusses the use of vasoactive medications in the pediatric setting.

Outcomes:

≥ 92% of participants will have increased knowledge and confidence in their ability to administer vasoactive intravenous medications safely.

Objectives:

After completing this continuing education course, the participant will be able to:

1. Explain when vasoactive medications are indicated.
2. Identify the parameters and titration of critical care medications.
3. Define titration, vasopressor, inotrope, catecholamine, adrenergic, vasodilator, and antiarrhythmic.
4. Determine vasoactive drugs, infusion rates, and other medicines for critically ill patients.
5. Specify how to calculate and verify drug mixtures every time a critical drug is administered.
6. Outline the basic principles of administering vasoactive medications to the pediatric patient.

Disclosures:

CEUFast Inc. and the course planning team for this educational activity do not have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.